Active pharmaceutical ingredients : development, manufacturing, and regulation
โ Scribed by Stanley Nusim
- Publisher
- Informa Healthcare
- Year
- 2010
- Tongue
- English
- Leaves
- 452
- Series
- Drugs and the pharmaceutical sciences, v. 205
- Edition
- 2
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Table of Contents
Content: Bulk drugs : the process development task / Carlos B. Rosas --
Bulk drugs : process design, technology transfer, and first manufacture / Carlos B. Rosas --
Design and construction of API manufacturing facilities / Steven Mongiardo --
Regulatory affairs : requirements and expectations / John Curran --
Regulatory affairs : guidelines, evolving strategies, and issues / John Curran --
Validation of active pharmaceutical ingredients / James Agalloco and Phil DeSantis --
Quality of active pharmaceutical ingredients / Michael C. Vander Zwan and Carlos Yuraszeck --
Environmental control / Bruce Wallington --
Thermochemical process safety : an introduction / Carlos B. Rosas --
Design and operating practices for safety / Stanley S. Grossel --
Plant operations / Stanley H. Nusim --
Sterile bulk active pharmaceutical ingredient production / James Agalloco and Phil DeSantis --
Biological production of active pharmaceutical intermediates / Max J. Kennedy, Randolph L. Greasham, and Stephen W. Drew --
Supply management / Victor J. Catalano --
Equipment maintenance and reliability / Kaizad P. Sunavala.
๐ SIMILAR VOLUMES
Focusing on the three most critical components that successfully bring an API to market-process development, manufacturing, and governmental regulation and approval-this reference serves as a step-by-step guide to the planning and clear understanding of the bulk manufacturing of APIs. This guide off
This guide offers current and timely discussions of the process development cycle, design engineering, the approval process, quality control and assurance, and validation, as well as plant manufacturing activities including materials management, maintenance, and safety.
The book reviews the history of current brand and generic business in pharmaceuticals manufacturing practices. Based on examples, the reader can interpolate, extrapolate and exploit mutual behavior (physical and chemical properties) of chemicals to design and commercialize processes that fulfi ll th